"Visit Bon Secours Hematology & Oncology in Greenville, South Carolina. Bon Secours Hematology & Oncology is one of the many Cancer Care & Oncology locations at Bon Secours providing good help to those in need."

During the past decade, Upstate Oncology Associates conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Upstate Oncology Associates" are "Chronic Lymphocytic Leukemia" (1 trials), "DLBCL Transformed From Indolent Lymphoma" (1 trials), "Diffuse Large B-cell Lymphoma" (1 trials), "Follicular Grade 3 Lymphoma" (1 trials) and "Post-essential Thrombocythemia Myelofibrosis" (1 trials). Many other conditions were trialed in "Upstate Oncology Associates" in a lesser frequency.

Most popular intervention types in "Upstate Oncology Associates" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Best Available Therapy" (1 trials), "Gemcitabine + Rituximab" (1 trials), "Idelalisib" (1 trials), "Ofatumumab" (1 trials) and "Pacritinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Upstate Oncology Associates" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Upstate Oncology Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Upstate Oncology Associates, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Upstate Oncology Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".